Cryoprecipitate prepared from plasma frozen within 24 hours after phlebotomy contains acceptable levels of fibrinogen and VIIIC

Transfusion

Volumn 50, Issue 5, 2010, Pages 1014-1018

  Yazer, Mark H ^a   Triulzi, Darrell J ^a   Hassett, Andrea Cortese ^a   Kiss, Joseph E ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8 CONCENTRATE; FIBRINOGEN; FRESH FROZEN PLASMA; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; BLOOD DONOR; CLINICAL ARTICLE; CONTROLLED STUDY; CRYOPRECIPITATE; HUMAN; IN VITRO STUDY; MALE; PHLEBOTOMY; RANDOM SAMPLE;

ADULT; BLOOD PRESERVATION; CRYOPRESERVATION; FACTOR VIII; FIBRINOGEN; HUMANS; MALE; MIDDLE AGED; PHLEBOTOMY; TIME FACTORS; VON WILLEBRAND FACTOR;

EID: 77951674133     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2009.02535.x     Document Type: Article

References (21)

1. Triulzi DJ, Blumberg N. Variability in response to cryoprecipitate treatment for hemostatic defects in uremia. Yale J Biol Med 1990 63 : 1 7. (Pubitemid 20186948)
2. Janson PA, Jubelirer SJ, Weinstein MJ, Deykin D. Treatment of the bleeding tendency in uremia with cryoprecipitate. N Engl J Med 1980 303 : 1318 22. (Pubitemid 11194456)
3. Mannucci PM, Remuzzi G, Pusineri F, Lombardi R, Valsecchi C, Mecca G, Zimmerman TS. Deamino-8-D-arginine vasopressin shortens the bleeding time in uremia. N Engl J Med 1983 308 : 8 12. (Pubitemid 13211265)
4. Alport EC, Callum JL, Nahirniak S, Eurich B, Hume HA. Cryoprecipitate use in 25 Canadian hospitals: commonly used outside of the published guidelines. Transfusion 2008 48 : 2122 7.
5. Schofield WN, Rubin GL, Dean MG. Appropriateness of platelet, fresh frozen plasma and cryoprecipitate transfusion in New South Wales public hospitals. Med J Aust 2003 178 : 117 21.
6. Pantanowitz L, Kruskall MS, Uhl L. Cryoprecipitate. Patterns of use. Am J Clin Pathol 2003 119 : 874 81.
7. Brecher ME, editor. Technical manual. 16th ed.
8. US Department of Health and Human Services. The 2007 nationwide blood collection and utilization survey report.
9. Triulzi DJ, Kleinman S, Kakaiya RM. The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion-related acute lung injury risk reduction strategy. Transfusion 2009 49 : 1825 35.
10. Silliman CC. The two-event model of transfusion-related acute lung injury. Crit Care Med 2006 34 (5 Suppl S124 131.
11. Yazer MH, Cortese-Hassett A, Triulzi DJ. Coagulation factor levels in plasma frozen within 24 hours of phlebotomy over 5 days of storage at 1-6 degrees C. Transfusion 2008 48 : 2525 30.
12. von Heymann C, Keller MK, Spies C, Schuster M, Meinck K, Sander M, Wernecke KD, Kiesewetter H, Pruss A. Activity of clotting factors in fresh-frozen plasma during storage at 4 degrees C over 6 days. Transfusion 2009 49 : 913 20.
13. Scott E, Puca K, Heraly J, Gottschall J, Friedman K. Evaluation and comparison of coagulation factor activity in fresh-frozen plasma and 24-hour plasma at thaw and after 120 hours of 1-6 degrees C storage. Transfusion. In press.
14. Caudill JS, Nichols WL, Plumhoff EA, Schulte SL, Winters JL, Gastineau DA, Rodriguez V. Comparison of coagulation factor XIII content and concentration in cryoprecipitate and fresh-frozen plasma. Transfusion 2009 49 : 765 70.
15. Hoffman M, Jenner P. Variability in the fibrinogen and von Willebrand factor content of cryoprecipitate. Implications for reducing donor exposure. Am J Clin Pathol 1990 93 : 694 7. (Pubitemid 20151131)
16. Yousef H, Neurath D, Freedman M, Rock G. Cryoprecipitate production: the use of additives to enhance the yield. Clin Lab Haematol 2006 28 : 237 40. (Pubitemid 44114634)
17. Hornsey VS, Krailadsiri P, MacDonald S, Seghatchian J, Williamson LM, Prowse CV. Coagulation factor content of cryoprecipitate prepared from methylene blue plus light virus-inactivated plasma. Br J Haematol 2000 109 : 665 70. (Pubitemid 30415200)
18. Keeling DM, Luddington R, Allain JP, Lawrie AS, Williamson LM. Cryoprecipitate prepared from plasma virally inactivated by the solvent detergent method. Br J Haematol 1997 96 : 194 7. (Pubitemid 27047552)
19. Rock GA, Cruickshank WH, Tackaberry ES, Palmer DS. Improved yields of factor VIIIC from heparinized plasma. Vox Sang 1979 36 : 294 300.
20. Shanbrom E, Owens WJ. A novel method to enhance the formation of cryoprecipitate from fresh plasma. Blood 2001 98 : 60a. (Pubitemid 33785696)
21. Alakech B, Miller B, Berry TH, Ambruso DR. Coagulation profile for cryoprecipitate produced from 24-hour stored whole blood. Lab Med 2009 40 : 540 3.